Preclinical Evaluation of (68)Ga- and (177)Lu-Labeled Integrin alpha(v)beta(6)-Targeting Radiotheranostic Peptides. Ganguly T, Bauer N, Davis RA, Foster CC, et al. J Nucl Med 2023;64:639-644.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ganguly T, Bauer N, Davis RA, Foster CC, et al. Preclinical Evaluation of (68)Ga- and (177)Lu-Labeled Integrin alpha(v)beta(6)-Targeting Radiotheranostic Peptides. J Nucl Med 2023;64:639-644.
PMID: 36207137